Study Confirms Increased CVT With AstraZeneca COVID Vaccine Study Confirms Increased CVT With AstraZeneca COVID Vaccine
Rates of cerebral venous thrombosis and thrombocytopenia were higher in patients who received the AstraZeneca COVID-19 vaccine in three Nordic countries.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news
More News: AstraZeneca | Cardiology | Covid Vaccine | COVID-19 | Heart | Study | Thrombocytopenia | Thrombosis | Vaccines